They facilitate this by upregulating VEGF markers and downregulating the tumor suppressor PTEN, activating the PI3K/Akt and EP4 signaling pathways, which are critical for angiogenesis and tumor progression [134]. The gene discussed is AKT1; the disease is neoplasm.